BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. Jan 21, 2027; 33(3): 123685
Published online Jan 21, 2027. doi: 10.3748/wjg.123685
Table 1 Clinicopathology and imaging features of the included patients, median (interquartile range)/n (%)
Characteristics
Total (n = 417)
Training set (n = 292)
Validation set (n = 125)
P value
Time (months)48.00 (30.00, 71.00)47.00 (30.00, 71.00)50.00 (31.00, 71.00)0.568
Age (years)0.847
    ≤ 60269 (64.5)187 (64.0)82 (65.6)
    > 60148 (35.5)105 (36.0)43 (34.4)
Gender0.310
    Male211 (50.6)153 (52.4)58 (46.4)
    Female206 (49.4)139 (47.6)67 (53.6)
Chemotherapy0.773
    No214 (51.3)148 (50.7)66 (52.8)
    Yes203 (48.7)144 (49.3)59 (47.2)
Ki-67 index0.556
    ≤ 10345 (82.7)239 (81.8)106 (84.8)
    > 1072 (17.3)53 (18.2)19 (15.2)
Mitotic count0.647
    ≤ 5243 (58.3)168 (57.5)75 (60.0)
    6-1082 (19.7)56 (19.2)26 (20.8)
    > 1092 (22.1)68 (23.3)24 (19.2)
Location0.777
    Stomach271 (65.0)188 (64.4)83 (66.4)
    Non-stomach146 (35.0)104 (35.6)42 (33.6)
Tumor size0.546
    ≤ 5 cm201 (48.2)140 (47.9)61 (48.8)
    5.1-10 cm165 (39.6)113 (38.7)52 (41.6)
    > 10 cm51 (12.2)39 (13.4)12 (9.6)
Boundary0.996
    Clear342 (82.0)240 (82.2)102 (81.6)
    Unclear75 (18.0)52 (17.8)23 (18.4)
Contour0.288
    Regular133 (31.9)88 (30.1)45 (36.0)
    Irregular284 (68.1)204 (69.9)80 (64.0)
Calcification0.230
    No346 (83.0)247 (84.6)99 (79.2)
    Yes71 (17.0)45 (15.4)26 (20.8)
Ulceration0.272
    No307 (73.6)220 (75.3)87 (69.6)
    Yes110 (26.4)72 (24.7)38 (30.4)
Growth pattern0.476
    Endoluminal88 (21.1)57 (19.5)31 (24.8)
    Exophytic201 (48.2)143 (49.0)58 (46.4)
    Mixed128 (30.7)92 (31.5)36 (28.8)
Enhancement pattern0.703
    Homogeneous100 (24.0)68 (23.3)32 (25.6)
    Heterogeneous317 (76.0)224 (76.7)93 (74.4)
Degree of enhancement0.643
    Mild90 (21.6)60 (20.5)30 (24.0)
    Moderate151 (36.2)105 (36.0)46 (36.8)
    Severe176 (42.2)127 (43.5)49 (39.2)
EFDV0.717
    No153 (36.7)105 (36.0)48 (38.4)
    Yes264 (63.3)187 (64.0)77 (61.6)
Peripheral fat infiltration0.632
    No315 (75.5)223 (76.4)92 (73.6)
    Yes102 (24.5)69 (23.6)33 (26.4)
Direct organ invasion0.665
    No395 (94.7)278 (95.2)117 (93.6)
    Yes22 (5.3)14 (4.8)8 (6.4)
Table 2 Exploration of independent influencing factors and construction of predictive models

ModelLasso
Modelintegrated
HR (95%CI)
P value
HR (95%CI)
P value
Tumor size (cm)
≤ 5Reference
5.1-101.557 (0.718-3.379)0.262
> 102.058 (0.792-5.353)0.139
EFDV
NoReferenceReference
Yes4.250 (1.495-12.080)0.0073.196 (1.115-9.157)0.031
Peripheral fat infiltration
NoReferenceReference
Yes2.281 (1.144-4.551)0.0191.229 (0.620-2.435)0.555
Ki-67 (%)
≤ 10ReferenceReference
> 102.722 (1.484-4.993)0.0011.889 (1.065-3.351)0.030
RSF score1.173 (1.104-1.247)< 0.001


Write to the Help Desk